Changing Course: Reversing Direct Oral Anticoagulants in the Emergency Department

Wednesday, October 14th, 2020
6:45 PM – 7:45 PM

How effectively are you managing DOAC-associated life-threatening bleeds in your emergency department?

Management of patients who require rapid reversal of urgent DOAC-associated bleeding is challenging. This CME activity will provide you with the tools you need to deliver individualized, safe, and effective care for these patients.

Program Overview

The development of direct oral anticoagulants (DOACs) has advanced the therapeutic landscape for the management of thromboembolic events. Specific agents that rapidly reverse the effects of DOACs are now available and offer safe and effective options for patients who experience an emergency DOAC-associated bleeding event. This ACEP Chapter Educational Lecture Series will offer:

  • Clinical pearls for the assessment of bleeding severity in patients receiving DOACs
  • Expert-guided insights to rapid reversal of urgent DOAC-associated bleeding
  • Clinical decision support tools to optimize outcomes in patients requiring reversal of DOACs

Target Audience

Emergency medicine physicians and physician assistants

Learning Objectives

Upon completion of this activity, learners should be better able to:

  • IDENTIFY the signs and symptoms of severe bleeding in patients receiving DOAC therapy
  • ASSESS anticoagulant activity in individuals who present with DOAC-associated bleeding or who require emergency surgery
  • DETERMINE appropriate reversal agents based on the type of anticoagulant, dose, timing of last dose, and indication
  • IMPLEMENT local protocols for evaluating patients and managing DOAC-associated bleeding

Faculty Presenter

Christopher W. Baugh, MD, FACEP
Vice Chair of Clinical Affairs
Department of Emergency Medicine
Brigham and Women’s Hospital
Associate Professor of Emergency Medicine
Harvard Medical School
Boston, MA